SureTrader
Home > Boards > US OTC > Medical - Equipment >

Arrayit Corporation (ARYC)

ARYC RSS Feed
Add ARYC Price Alert      Hide Sticky   Hide Intro
Moderator: techmover, BZstocks, DDStocks, HighYieldStocks, Mykkus, SK510
Search This Board: 
Last Post: 4/21/2018 3:06:15 PM - Followers: 454 - Board type: Free - Posts Today: 21

Welcome to the Ihub Arrayit Corporatio (ARYC) board  


Arrayit Corporation (ARYC) is a Silicon Valley biotech company that is currently trading at a low fraction of its actual worth. Please review the listed links, see the actual sales of this Silicon Valley company through their daily updates on Twitter (@Arrayit) and understand the incredible potential that this company has.  

Arrayit Corporation  
927 Thompson Place  
Sunnyvale, CA 94085  
USA  
Phone 408-744-1331  
FAX 408-744-1711  
Email arrayit@arrayit.com  
Web www.arrayit.com

 

Publications and Social Networking:  

Arrayit products have been featured in 5,000+ scientific publications.
Follow Arrayit on Twitter, Facebook, Yahoo Finance, $ARYC and iHub.  

https://twitter.com/arrayit
https://www.facebook.com/Arrayit
https://finance.yahoo.com/quote/ARYC?ltr=1
https://www.youtube.com/ 
Arrayit Corporation News Feed
Arrayit Store
 
 
Corporate Overview
Arrayit Corporation is a leading life sciences company providing innovative products and services to empower scientists and clinicians to explore the human genome as well as the genomes of plants and animals. Arrayit's worldwide business position leverages the company's widely used patented microarray manufacturing platform and revolutionary VIP™ genotyping technology. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. Novel insights into the function of genes and proteins, early stage disease diagnostics, better and safer medicines, and more nutritional crop plants are some of the many aspects of human health empowered by Arrayit technology.
Corporate Philosophy
Arrayit is an exciting and innovative public company that strives to increase shareholder equity by inventing, developing, manufacturing and supplying sophisticated life sciences products and services to an extensive customer base spanning 50 countries. Our corporate philosophy is embodied by a highly skilled, multidisciplinary team of investors, business professionals, scientists, engineers and executive and support staff who place shareholder value, product quality, customer service and price competitiveness as our highest priorities. Arrayit empowers decisive strategic advantage and large return on investment for our customers in the research, pharmaceutical, diagnostic, and health care markets.

Corporate History
Arrayit Corporation was founded in 1993 by Rene' Schena and Todd Martinsky as TeleChem International, Inc, a chemical import and export company specializing in plastics, water soluble fertilizers, alternative fuels, and the life sciences. After several years of successful revenues growth, the company expanded in 1999 by adding Dr. Mark Schena and Paul Haje, who together with Ms. Schena and Mr. Martinsky, founded Arrayit Life Sciences, a division of TeleChem International, Inc. Arrayit sought to build on the opportunities created by the deciphering of the human genome and the rise of microarray technology. Arrayit microarrays are sophisticated glass substrates containing large collections of DNA and protein spots that allow all 25,000 human genes and every major protein in the human body to be analyzed in a few hours. Arrayit VIP™ microarrays enable the analysis of the DNA from 100,000 patients in one day. Since 1999, Arrayit has has build a powerful portfolio of patents, trade secrets, and more than 650 life sciences products. The company was featured on the television series NOVA in 2001, received successive appointments to the Inc. 500 list in 2002 and 2003, and has received numerous local awards including the Rising Star award from the City of Sunnyvale and the Silicon Valley 50 award in 2003. The company changed its name to Arrayit Corporation and began trading on the OTC Bulletin Board in 2009 as ticker symbol ARYC. The company's products and services are used in the life sciences, pharmaceutical, and diagnostics markets, which are estimated at $690 billion in annual revenue.
 


No share increase per CEO (I.E. NO DILUTION)

Outstanding: 1,055,279,527 
Restricted: 21,490,723 
Float: 1,033,788,804 


Standard Registrar and Transfer Company, Inc. 
440 East 400 South, Suite 200 
Salt Lake City, UT 84111 
Phone: 801-571-8844 or 801-596-2150 
Fax: 801-328-4058

Estimated earnings of $8 million last year and it is also located in the heart of Silicon Valley near Apple, Yahoo, AMD, Juniper, MBZ, LinkedIn, Facebook and many, many other leaders of the tech industry. 

2 contracts signed last year for a total of approximately $51 million over the next 3 years ......

No other OTC company has the potential of ARYC  

Arrayit's new corporate headquarters, features 15,000 square feet of modern industrial space including 45 parking spaces, offices, conference rooms, demonstration laboratories, class 100 cleanrooms, and manufacturing and shipping facilities

Arrayit Headquarters Drive By(Click to view)
Arrayit Store sales exceed $55,000,000 all time on 230,706 products and services sold since on-line inception
 

 


 

ARYC also owns 40 million shares of AVDX(Click to visit Advant Diagnostics)

Enabling physicians to make personalized treatment recommendations for cancer patients

Avant Diagnostics, Inc. (formerly known as Theranostics Health, Inc.) is a medical diagnostic technology company focused on commercializing innovative biomarker technologies that have the potential to dramatically improve treatment outcomes in the areas of oncology and neurology. The Company's lead technology, called Theralink(r), was developed to empower cancer treating physicians with actionable information make time sensitive treatment decisions for their patients. Theralink was designed to inform physicans which treatments are likely to be effective for their patients at any given moment in time, and also identify which treamtents are unlikely to be effective. This information has the potential to improve treatment efficacy and reduce side effects by foregoing ineffective therapy.

Cancer tumor biomarker profiling: Driving innovation in personalized medicine

At Avant Diagnostics, our approach is based on more than 10 years of research and development that informs our philosophy the genetic information alone is insufficient to make patient specific treatment recommendations. Our phospho-proteomic approach, which focuses on measuring the quantity and intensity of drug target activation in the tumor tissue following standard biopsy procedures, exploits our understanding of drug-receptor interaction that is the driver of treatment response . Our advanced technology is being developed to reduce the prescription of ineffective, toxic treatments and guide physicians towards therapies that are most likely to lead to positive responses to treatment. Our large panel of markers targeted at already-approved FDA drugs, as well as certain investigational therapies, makes Theralink an invaluable tool for oncologists.

Market opportunity: Cancer biomarkers market expected to reach $33B by 2025

According to Grand View Research, the market for cancer biomarkers is expected to grow from $10.3B in 2016 to $33.7B by 2025, representing a compound annual growth rate (CAGR) of 14.6%. The market is currently comprised primarily of genetic biomarkers that have good predictive value on a population basis, but limited value on an individual patient basis. Proteomic markers represent a growing segment of the cancer biomarker market, and offer the promise to improve individual patient outcomes based upon the individual patient's tumor proteomic profile.

Within the proteomic cancer biomarker category, phosphoprotein analysis represents a uniquely positioned asset class that can more robustly predict treatment outcomes based upon the molecular mechanisms driving tumor growth and treatment resistance. As such, the Company believes it has the potential to be the market leader in this phospho-proteomic subcategory.
 

OvaDx® Ovarian Cancer Diagnostic Test

In Development

Arrayit Diagnostics, Inc. provides the market's first large panel biomarker screening test for ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Arrayit Diagnostics will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.

Human genome



SureTrader
ARYC
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
ARYC News: Statement of Ownership (sc 13g) 03/22/2018 02:12:50 PM
ARYC News: Initial Statement of Beneficial Ownership (3) 03/19/2018 06:37:10 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#75691  Sticky Note Below are my finding from my tour at Jeffpacman 03/30/18 11:28:30 AM
#74305  Sticky Note UPDATED 3-21: ARYC Potential revenue streams partial list: BZstocks 03/21/18 08:56:51 PM
#70614  Sticky Note NEWS out!! *********************** Arrayit sales and marketing team Mykkus 03/01/18 07:44:03 PM
#67208  Sticky Note Silicon Valley Biotech Arrayit (ARYC) is located in SK510 02/07/18 05:39:06 PM
#66938  Sticky Note For those who are new to Arrayit Corporation, HighYieldStocks 02/06/18 09:21:39 AM
#66899  Sticky Note New investors: Please take a moment to review DDStocks 02/05/18 06:05:23 PM
#77812   That contract, alone, is twice the ARYC Market Cap UndervaluedStocks 04/21/18 03:06:15 PM
#77811   Seems kind of low.... cheapest I’ve seen pinner TravO 04/21/18 03:02:32 PM
#77810   I know, lol! My friend got a law Liuhisn 04/21/18 02:35:26 PM
#77809   Arrayit advanced blood cards allow collection, fractionation, sampling, Ace508 04/21/18 02:19:13 PM
#77808   Ya that sounds about right. Thx Jeffpacman 04/21/18 01:26:01 PM
#77807   Pinnertest Promotes Nutrition & Wellness This Award Season Ace508 04/21/18 01:25:39 PM
#77806   Manufactured by Arrayit Corporation, Pinnertest is a blood-based UndervaluedStocks 04/21/18 01:24:00 PM
#77805   Thanks UVS. I believe ARYC will soon rise Ace508 04/21/18 01:15:55 PM
#77804   As am I! Holding and patiently waiting for filings DDStocks 04/21/18 01:15:27 PM
#77803   I believe this is it, Jeff: 9-12-2016: Arrayit signs UndervaluedStocks 04/21/18 12:57:41 PM
#77802   Does anyone know when Arrayit recieved the contract Jeffpacman 04/21/18 12:52:24 PM
#77801   Patience is a virtue. Learn to wait or techmover 04/21/18 12:41:25 PM
#77800   Two to three years for fins is a Liuhisn 04/21/18 12:22:26 PM
#77799   #shoutoutsaturday - Check out @globalnewyorker's post about her Ace508 04/21/18 12:04:07 PM
#77798   I'm still confident, as are many other, still BZstocks 04/21/18 12:01:18 PM
#77797   Nice thought but I doubt that. techmover 04/21/18 09:08:06 AM
#77796   What’s Pinnertest by Arrayit? Pinnertest utilizes advanced IgG (FC UndervaluedStocks 04/21/18 08:56:25 AM
#77795   Max price will be 0.001 in 4 years Starlight84 04/21/18 04:49:05 AM
#77794   “The services on this website are provided by Ace508 04/21/18 02:56:33 AM
#77793   AllergyGo’s home allergy test allows you to easily Ace508 04/21/18 02:51:03 AM
#77792   New Tweet from Pinnertest: Our Lab, Arrayit Corporation, Ace508 04/21/18 02:45:06 AM
#77791   at least it is close and wont cost hbhmb 04/20/18 11:18:49 PM
#77790   Not here. Not for those who know what UndervaluedStocks 04/20/18 07:37:58 PM
#77789   All we can do is wait. Should not Liuhisn 04/20/18 07:14:41 PM
#77788   THat's fine...let it wane. I'm here for at techmover 04/20/18 07:12:18 PM
#77787   Confidence is beginning to wane waiting for these fins! Liuhisn 04/20/18 07:11:30 PM
#77786   Only 3 shares? Oh yeah, MMs at their techmover 04/20/18 07:02:39 PM
#77785   EOD paint job? Liuhisn 04/20/18 06:55:24 PM
#77784   Arrayit sales and marketing team invited to the Ace508 04/20/18 03:57:24 PM
#77783   3 shares? Haha that can’t be real. SK510 04/20/18 03:22:12 PM
#77782   OLD TWEET - without the financials all hbhmb 04/20/18 02:14:13 PM
#77781   NEW tweet...Arrayit clinical team invited to the prestigious HighYieldStocks 04/20/18 01:07:24 PM
#77780   NEW tweet...Arrayit sales and marketing team reports $145,000 HighYieldStocks 04/20/18 01:06:59 PM
#77779   NEW tweet...Arrayit shipping department reports expedited microarray life HighYieldStocks 04/20/18 01:06:41 PM
#77778   NEW tweet...Arrayit sales and marketing team reports microarray HighYieldStocks 04/20/18 01:06:17 PM
#77777   NEW tweet...Arrayit sales and marketing team reports $5,000 HighYieldStocks 04/20/18 01:06:06 PM
#77776   NEW tweet...Arrayit shipping department ships microarray life sciences HighYieldStocks 04/20/18 01:05:55 PM
#77775   NEW tweet...Arrayit shipping department ships $3,100 microarray life HighYieldStocks 04/20/18 01:05:47 PM
#77774   Also claiming it’d be nice if more posts SK510 04/20/18 12:59:37 PM
#77773   Which part of my post wasn’t factual? I SK510 04/20/18 12:58:56 PM
#77772   Big money! Keep it coming ARYC! New Tweet: Arrayit Ace508 04/20/18 12:44:24 PM
#77764   If you’re not happy with the stock, you UndervaluedStocks 04/20/18 11:46:13 AM
#77763   It would be nice if posts on this rh22 04/20/18 11:45:28 AM
#77762   Ok gotcha! Godsnunba1 04/20/18 11:44:16 AM
#77761   Thank you for a dose of reality SK UndervaluedStocks 04/20/18 11:43:28 AM
#77760   Most judge's dockets are chock a block. rh22 04/20/18 11:41:57 AM
#77759   OK thanks! Can a judge reject it and Godsnunba1 04/20/18 11:40:05 AM
#77757   According to the filings ARYC'S management - Rene, rh22 04/20/18 11:36:54 AM
#77756   No date has been set by the judge rh22 04/20/18 11:33:21 AM
#77755   Arrayit shipping department ships $3,100 microarray life sciences Ace508 04/20/18 11:32:08 AM
PostSubject